The level of hypoxia in primary tumors has been described to influence response to treatment. The aim of the present study was to investigate the impact of pretreatment oxygen level measurements in spontaneous canine tumors on treatment outcome. Material and Methods: Data of pretreatment tumor oxygenation status and local tumor response after primary radiation therapy in a group of spontaneously occurring tumors in dogs (n = 52) was collected. Radiation therapy was given with curative (14-17 × 3-3.5 Gy) or palliative intent (3 × 8 Gy or 4-5 × 6 Gy). Progression-free interval and overall survival were correlated to polarographically measured tumor oxygenation status. Results: In the curatively irradiated group, tumors with median pO 2 values ≤ 10 mmHg tended to have shorter median progression-free interval compared to better oxygenated tumors (246 vs. 739 days). The same trend could be shown for overall survival (330 vs. 745 days), indicating a cutoff value in this region. In the group treated with lower doses of radiation, the level of oxygen was no longer found to be of prognostic value; however, in this group hemoglobin had a significant impact on outcome. Conclusion: In curatively irradiated spontaneous canine tumors, tumor hypoxia was found to be a prognostic indicator, independent of tumor histologies and volume.
Introduction
Hypoxic conditions in tumors are known to modulate the sensitivity of cancer cells to various treatment modalities [18, 19, 29] . Radiation sensitivity, for example, decreases for cells in environments with pO 2 values below mixed-venous blood (40 mmHg) , and for values below 3-4 mmHg, the sensitivity is halved, compared to well-oxygenated tissues [38] . Tumor hypoxia, measured by invasive oxygen electrodes, has been found prognostic for tumor control and treatment outcome in a variety of human tumors [6, 12, 14, 19, 27, 28, 33, 40] .
The presence, prevalence and distribution of hypoxic tumor cells in spontaneous canine tumors have been detected by several techniques and related to tumor and patient characteristics [2, 11, 31] . The binding of nitroimidazoles, hypoxic cell-marking substances, has been studied and has proven the presence of hypoxia in canine tumors [11] . Imaging techniques that quantitate hypoxic cells, using a nitroimidazole compound labeled with a radioisotope [ 18 F]-misonidazole (FMISO), have been described [15, 32] . Bruehlmeier et al. used a similar technique to describe tumor hypoxia and perfusion in spontaneous canine tumors [7, 32] . Achermann et al. as well as Brurberg et al. recently documented the presence and changes of hypoxia in spontaneous canine tumors during fractionated radiotherapy using invasive polarographic needle electrodes and OxyLite fluorescence probes, respectively [2, 8] .
The influence of tumor oxygenation status on the response to radiation therapy has not been described for spontaneous canine tumors. In this study we aimed at investigating the impact of pretreatment oxygenation level measurements in spontaneous canine tumors on therapy outcome, including response to radiation therapy, progression-free interval (PFI) and overall survival. We also tried to identify whether there is an oxygen partial pressure (pO 2 ) to be found that appears to be a cutoff level indicative of prognosis between hypoxic and less hypoxic tumors. Furthermore, the dependence of influencing factors such as dose of radiation, hematologic parameters and tumor parameters was tested.
Material and Methods

Patients
Dogs with spontaneously originating malignant tumors treated with fractionated irradiation were included in the study. All dogs were client-owned pets that were presented for tumor therapy to the Section of Diagnostic Imaging and Radiation Oncology of the Vetsuisse Faculty, University of Zurich, Switzerland, from 2001 to 2004. Prior to treatment all dogs underwent diagnostic work-up as indicated for staging of the disease. All patients presented with macroscopic tumors. Primary tumor site and size, histopathologic differentiation and staging information were obtained.
Radiation Therapy
All dogs were treated with external-beam megavoltage radiation. Radiation was delivered with a 6-MV linear accelerator (Dynaray LA20; ABB/VARIAN) using 6-MV photons or 9-to 16-MeV electrons, as appropriate. Individualized treatment plans were generated using a 3-D computer treatment planning system (Varian CadPlan ® 6.0.8; Figure 1 ). Treatment protocols were delivered either with palliative (3 × 8 Gy on days 0, 7, 21 or 4-5 × 6 Gy, applied biweekly) or curative intent (14-17 × 3-3.5 Gy, applied in four or five fractions per week), resulting in an overall treatment time of 3.5 weeks.
pO 2 Measurements and Tumor Volumes
Polarographic tumor oxygen partial pressure measurements were performed as previously described in dogs by Achermann et al. [1, 2] . Tumor volume was calculated based on the formula: π/6 × height × width × depth, which approximately describes the volume of an ellipsoid [35] . The hypoxic subvolume (HSV) was calculated by the formula: volume (cm 3 ) × hypoxic fraction (% of pO 2 values ≤ 5 mmHg) [34] .
Patient Follow-up and Response to Treatment
Regular follow-up clinical reexaminations were performed in order to collect information about general performance and tumor status. Responses are defined in Table 1 and evaluated at the end of therapy, at 3 weeks or 3 months depending on tumor histology. Routine clinical follow-up visits were made every 6 months thereafter. PFI was determined from the first time point of tumor regression to the time of progressive disease, independent of completeness of previous response. Overall survival time was determined from the beginning of radiation therapy.
Statistical Analysis
Description of patient data, other than overall survival times, is given by mean (± SD [standard deviation]) unless otherwise . Although the tumor volumes and the HSV of the sarcoma group were significantly larger than the ones of the group with other histologies (p = 0.0007 and p = 0.019), no correlation between tumor volumes, hematologic parameters, and any of the oxygen parameters could be found. The relative frequency distribution of low oxygen levels in sarcoma and non-sarcoma histologies was not different; therefore for further analysis, the patients were split up according to their radiation treatment protocol.
Results
Patients
Treatment Protocols and Response to Treatment
Initial therapy consisted of radiation (n = 52) given with curative (n = 23) or palliative (n = 29) intent (mean total dose 50.5 Gy [± 3.5 Gy] vs. 27.3 Gy [± 4.9 Gy]). Seven patients each received additional chemotherapy or surgery. Response to treatment was observed in 51/52 patients (98%). Complete response could be observed in 18/52 patients (35%), partial response in 21/52 (40%), stable disease in 12/52 (23%), and progressive disease was seen in one case (2%; Table 1 ). At the time of analysis 14 patients were free of progression and 19 were still alive. Patients were followed up to death or the close-out date, and none was lost to follow-up. The mean and median follow-up times for patients still alive were 346 days (range: 52-1233 days) and 234 days, respectively. 25 patients died of tumor-related disease, four for other reasons, and in four cases cause of death could not be assessed.
Progression-Free Interval and Overall Survival
Univariate Models Curatively treated patients that experienced a complete response after initial treatment had a median PFI of 810 days (95% CI 605-1,015 days), with non-complete response the PFI was 246 days (95% CI 198-293 days; p = 0.014). We found significant correlations between the percentages of pO 2 vaues ≤ 10, 5 and 2.5 mmHg and shorter duration of the PFI in the curatively treated patients (Table 2 ). PFI for curatively Table 3 : for patients of the curatively treated group, high amounts of oxygen levels ≤ 5 or 2.5 mmHg resulted in a shorter overall survival time. Larger tumor volumes, HSV and low Hb levels were associated with shorter overall survival in the palliatively treated group.
Multivariate Models Multiple stepwise forward and backward analyses showed that for PFI and overall survival in the patients of the curatively treated group, the oxygen values were the only prognostic factors. In the palliatively treated group, PFI was influenced by Hb only, while overall survival was influenced by Hb levels, age and HSV (Table 4) .
Discussion
This study found that the tumors with the highest number of pO 2 values ≤ 10, 5 and 2.5 mmHg were related to the poorest outcome regarding PFI and overall survival for patients treated with curative intent. This finding was independent of tumor histology and volume. Also, a trend to longer PFI in tumors with median pO 2 values > 10 mmHg could be shown, indicating a possible presence of a "cutoff" point in this region as described by Höckel et al. for human cervical cancers [18, 19] .
Invasive oxygen electrode measurement studies have demonstrated the presence of hypoxia in a variety of human tumor types and sites [5, 6, 14, 24, [26] [27] [28] , and a positive correlation has been demonstrated between the presence of hypoxia and poor treatment outcome. Nordsmark et al. found tumor Table 3 . Univariate proportional hazards Cox regression results for influences on survival. For abbreviations see Table 2 . [14] . We learned from other authors [30] and from our own experience [1, 2] that sarcomas tend to be severely hypoxic. Brizel et al. [5] described a longer disease-free survival for patients with sarcomas of median pO 2 > 10 mmHg, and also found more hypoxia was present in larger tumors of mesenchymal origin [4] . However, in this regard no significance could be found in our data. Our findings are supported by findings first described by Vaupel et al. [39] , stating that the occurrence of radiobiological hypoxia neither correlates with pathologic stage nor grade, and by the majority of published studies that do not support the paradigm that larger tumors are more hypoxic than smaller tumors [19, 20, 22, 23, 26, 34, 36] .
In our study the amount of tumor hypoxia only influenced the outcome in the group treated with curative intent (high doses) and not in the group that received lower total doses. A similar finding has been made by Brizel et al., where a higher radiation dose was related to longer overall survival, disease-free survival and duration of local-regional control [3] . Interestingly, in the palliatively treated group, where hypoxia was not found to be a determinant factor, the PFI and overall survival times correlated negatively with Hb levels. Some studies describe an association between anemia and poor tumor oxygenation, for example in rats [21] , and worse prognoses for pre-, mid-, or end-treatment Hb levels for various tumor groups in humans have been reported [9, 10, 13, 16, 17, 25, 33, 34, 37 ]. However, pretreatment Hb level is more likely an indicator of prognosis in terms of the patient's general condition and the clinical relevance of Hb levels during and at the end of radiation therapy might be greater [13, 28] .
Conclusion
Our findings support the hypothesis that tumor hypoxia in spontaneous canine tumors has an impact on PFI and overall survival time. Canine tumors contain large amounts of hypoxic regions, and tumor hypoxia was found to be a strong prognostic indicator, independent of tumor histologies and volume.
